NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQ: MQ) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Marqeta investors who were adversely…
Tag: PR Newswire
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in MGP Ingredients, Inc. (“MGP Ingredients, Inc.” or the “Company”) (NASDAQ: MGPI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of MGP Ingredients, Inc….
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Joint Stock Company Kaspi.kz (“Joint Stock Company Kaspi.kz” or the “Company”) (NASDAQ: KSPI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Joint…
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied…
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Capri Holdings Limited (“Capri Holdings” or the “Company”) (NYSE: CPRI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Capri Holdings investors who…
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Cassava Sciences, Inc. (“Cassava Sciences, Inc.” or the “Company”) (NASDAQ: SAVA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cassava Sciences,…
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. (“Kyverna Therapeutics, Inc.” or the “Company”) (NASDAQ: KYTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyverna…
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Regeneron investors…
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Revance investors who were…
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were…